title: [Clinical pathways in acute pancreatitis: recommendations for early multidisciplinary management. Scientific Committee of the SEMICYUC. Working Group on Infectious Diseases (GTEI-SEMICYUC)].
abstract: There is a growing body of evidence that early management of patients with acute pancreatitis may alter the natural course of disease and improve outcomes of patients. The aim of this paper is to optimize the management of patients with acute pancreatitis during the first 72 h after hospital admission by proposing several clinical care pathways. The proposed pathways are based on the SEMICYUC 2005 Recommendations with incorporation of the latest developments in the field, particularly the determinants-based classification of acute pancreatitis severity. The pathways also incorporate the "alarm signs", the use of therapeutic modalities known as PANCREAS, and the "call to ICU" criteria. Further studies will need to assess whether the adoption of these pathway reduces mortality and morbidity in patients with acute pancreatitis. The previous SEMICYUC guidelines on management of patients with acute pancreatitis in Intensive Care will need to be revised to reflect the recent developments in the field.
authors.affiliation: UCI-B, Complejo Hospitalario de Navarra (antiguo H. Virgen del Camino), Pamplona, España. enrique.maravi.poma@navarra.es
authors.forename: E
authors.initials: E
authors.lastname: Maraví Poma
authors.forename: C
authors.initials: C
authors.lastname: Laplaza Santos
authors.forename: B
authors.initials: B
authors.lastname: Gorraiz López
authors.forename: E
authors.initials: E
authors.lastname: Albeniz Arbizu
authors.forename: F
authors.initials: F
authors.lastname: Zubia Olascoaga
authors.forename: M S
authors.initials: MS
authors.lastname: Petrov
authors.forename: F A
authors.initials: FA
authors.lastname: Morales
authors.forename: M
authors.initials: M
authors.lastname: Aizcorbe Garralda
authors.forename: M
authors.initials: M
authors.lastname: Casi Villaroya
authors.forename: J A
authors.initials: JA
authors.lastname: Sánchez-Izquierdo Riera
authors.forename: V
authors.initials: V
authors.lastname: López Camps
authors.forename: E
authors.initials: E
authors.lastname: Regidor Sanz
authors.forename: M
authors.initials: M
authors.lastname: Loinaz Bordonabe
authors.forename: J L
authors.initials: JL
authors.lastname: do Pico
mesh_terms: D000208:Acute Disease; D000465:Algorithms; D000698:Analgesia; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003131:Combined Modality Therapy; D003422:Critical Care / Q000379:methods / Q000592:standards*; D019091:Critical Pathways; D019468:Disease Management; D004750:Enteral Nutrition; D005440:Fluid Therapy; D006801:Humans; D059325:Intra-Abdominal Hypertension / Q000209:etiology; D009102:Multiple Organ Failure / Q000209:etiology; D009336:Necrosis; D010180:Pancreatectomy / Q000379:methods; D010195:Pancreatitis / Q000145:classification / Q000175:diagnosis / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D010348:Patient Care Team; D012720:Severity of Illness Index; D012955:Societies, Medical; D013030:Spain
chemical_list: D000900:Anti-Bacterial Agents